Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-21-021341
Filing Date
2021-07-02
Accepted
2021-07-02 17:30:52
Documents
2
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 2776
2 POWER OF ATTORNEY (PUBLIC): POA MULLIGAN doc1.txt EX-24 4109
  Complete submission text file 0001127602-21-021341.txt   8525
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Issuer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ICAHN CAPITAL LP 767 FIFTH AVENUE, SUITE 4700 NEW YORK NY 10153
Business Address
Mulligan Richard (Reporting) CIK: 0001376247 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 211071659